Paradigm Biodevices, Inc.

Paradigm Biodevices is a medical device company specializing in minimally invasive surgical solutions for orthopedic fusion procedures, particularly autogenous bone grafting. The company has established clinical expertise through its flagship QuickDraw MIS Bone Harvester, a percutaneous bone harvesting system for iliac crest bone grafting that has been used in over 40,000 procedures at elite orthopedic hospitals across the United States and global markets. Paradigm has recently launched VisiCORE™, a proprietary next-generation bone harvester designed for extremity fusions, developed in collaboration with foot and ankle surgeon innovators. The company focuses on addressing surgical technique challenges in fusion procedures, enabling surgeons to harvest autograft bone with improved visibility, precision, and efficiency while maintaining the gold-standard composition of autograft scaffolds, cells, and signaling factors. Products are used in spine fusion and extremity fusion applications, serving orthopedic surgical centers, teaching hospitals, and specialized orthopedic programs. Paradigm holds ISO 13485 certification, demonstrating compliance with medical device quality management standards. The company participates actively in major orthopedic conferences including ACFAS, AOFAS, and NASS annual meetings, and provides hands-on surgical instruction and demonstration programs for surgeons.